WELLINGTON MANAGEMENT GROUP LLP - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$119,988,587
-8.9%
5,114,603
-1.9%
0.02%
-8.7%
Q1 2024$131,689,574
+95.7%
5,213,364
+80.9%
0.02%
+76.9%
Q4 2023$67,294,443
+60.5%
2,881,989
+247.7%
0.01%
+62.5%
Q3 2023$41,928,847
-0.4%
828,961
-8.0%
0.01%0.0%
Q2 2023$42,077,262
-5.2%
901,205
-22.3%
0.01%
-11.1%
Q1 2023$44,402,336
-7.5%
1,160,542
+32.5%
0.01%
-10.0%
Q4 2022$48,010,225
+77.0%
876,099
+10.0%
0.01%
+66.7%
Q3 2022$27,120,000
+308.6%
796,499
+13.4%
0.01%
+500.0%
Q2 2022$6,638,000
-79.0%
702,480
-68.5%
0.00%
-80.0%
Q1 2022$31,679,000
-20.2%
2,232,523
+19.0%
0.01%
-16.7%
Q4 2021$39,694,000
-6.9%
1,876,811
-1.6%
0.01%
-14.3%
Q3 2021$42,628,000
+4.2%
1,907,328
+15.6%
0.01%0.0%
Q2 2021$40,929,000
-8.6%
1,649,690
+6.9%
0.01%
-12.5%
Q1 2021$44,773,000
+3.9%
1,543,330
-7.6%
0.01%0.0%
Q4 2020$43,099,000
-21.9%
1,670,510
-6.8%
0.01%
-27.3%
Q3 2020$55,186,000
+26952.0%
1,792,313
+21762.8%
0.01%
Q2 2020$204,000
-96.3%
8,198
-96.7%
0.00%
-100.0%
Q4 2019$5,466,000
-10.4%
246,301
-8.1%
0.00%0.0%
Q3 2019$6,098,000
-4.1%
268,067
-19.3%
0.00%0.0%
Q2 2019$6,361,000332,1600.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
University of Wisconsin Foundation 423,849$9,943,49811.19%
Propel Bio Management, LLC 327,752$7,689,0624.99%
GENERAL ATLANTIC, L.P. 5,233,989$122,789,3823.86%
SILVERARC CAPITAL MANAGEMENT, LLC 625,087$14,664,5413.46%
Yiheng Capital Management, L.P. 1,434,179$33,645,8392.71%
Redmile Group, LLC 1,614,473$37,875,5372.29%
Boxer Capital, LLC 1,676,733$39,336,1562.07%
RTW INVESTMENTS, LP 5,431,985$127,434,3681.97%
Logos Global Management LP 800,000$18,768,0001.52%
MPM BioImpact LLC 385,990$9,055,3251.41%
View complete list of AKERO THERAPEUTICS INC shareholders